Patients

ACTOnco®+

To find appropriate treatment options for you, it is important to first understand what drives the growth of your tumor. In humans, about 400 genes play a role in different cancer signaling pathways, and alterations in these genes drive tumor growth by different mechanisms. ACTOnco®+ is a comprehensive cancer genomic profiling service that covers  440 cancer-related genes to uncover the mechanism your cancer uses to grow and find the most appropriate tailored therapy.

The most comprehensive cancer genomic profiling test that discovers the right treatment for you at the right time.

ACTOnco+ sequences 440 cancer-related genes and can detect all 4 classes of genomic alterations. With your completed tumor genomic profile, we generate a comprehensive report that effectively maximizes your treatment options.

ACTOnco+ is most suitable for patients with solid tumors 

■ Patients newly diagnosed with cancer

■ Patients to be treated with chemotherapy, hormonal therapy, targeted therapy, PARP1 inhibitors and immunotherapy for the first time  

■ Patients with recurrence or metastasis

■ Patients with resistance to existing treatment

Sample types:

Typical tissue samples include FFPE (formalin-fixed and paraffin-embedded) tissue, excessive body fluids associated with cancers such as lung water or ascites, etc.

Turnaround time:

14 calendar days after samples are received